| Literature DB >> 31639045 |
Jichang Li1, Zujian Qiao1,2, Wanying Hu1, Wei Zhang1, Syed Waqas Ali Shah3, Muhammad Ishfaq4.
Abstract
The thymus is a primary lymphoid organ and plays a critical role in the immune response against infectious agents. Baicalin is a naturally derived flavonoid famous for its pharmacological properties, but the preventive effects of baicalin against immune impairment remain unclear. We examined this effect in the context of Mycoplasma gallisepticum (MG) infection-induced structural damage in the chicken thymus. Histopathological examination showed that the compact arrangement of cells in the thymus was lost in the MG-infected group. Inflammatory cell infiltration and nuclear debris accumulated, and the boundary between the cortex and medulla was not clearly visible. The mRNA and protein expression of apoptosis-related genes were significantly increased in the MG-infected group compared to the control group and the baicalin group. The number of positively stained nuclei in the terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling (TUNEL) assay were increased in the MG-infected group. In addition, electron microscopic examination showed chromatin condensation, mitochondrial swelling and apoptotic vesicles in the MG-infected group. However, baicalin treatment significantly alleviated the oxidative stress and apoptosis induced by MG infection. Importantly, the abnormal morphology was partially ameliorated by baicalin treatment. Compared to the MG-infected group, the baicalin-treated group showed significantly reduced expression of apoptosis-related genes at both the mRNA and protein levels. Meanwhile, the nuclear factor erythroid 2-related factor 2 (Nrf2) signalling pathway and downstream genes were significantly upregulated by baicalin to counteract MG-induced oxidative stress and apoptosis in the thymocytes of chickens. In summary, these findings suggest that baicalin treatment efficiently attenuated oxidative stress and apoptosis by activating the Nrf2 signalling pathway and could protect the thymus from MG infection-mediated structural and functional damage.Entities:
Year: 2019 PMID: 31639045 PMCID: PMC6805401 DOI: 10.1186/s13567-019-0703-6
Source DB: PubMed Journal: Vet Res ISSN: 0928-4249 Impact factor: 3.683
List of primers used for qRT-PCR
| S. No. | Gene name | Primers (from 5′ to 3′) | Product length |
|---|---|---|---|
| 1 | TLR2-A | Forward 5′-TCGCTCCAACACCTTCGCATTC Reverse 5′-GATTGTCACCGTCGATCCTCAGC | 181 |
| 2 | TLR2-B | Forward 5′-TCCTCATCCTGGTGGTCGTTGG Reverse 5′-GGCTTCCGCTTGGCTTGGAG | 88 |
| 3 | TLR4 | Forward 5′-TTCGGTTGGTGGACCTGAATCTTG Reverse 5′-ACAGCTTCTCAGCAGGCAATTCC | 114 |
| 4 | NLRP3 | Forward 5′-GCTCCTTGCGTGCTCTAAGACC Reverse 5′-TTGTGCTTCCAGATGCCGTCAG | 150 |
| 5 | IL-10 | Forward 5′-CAGCACCAGTCATCAGCAGAGC Reverse 5′-GCAGGTGAAGAAGCGGTGACAG | 94 |
| 6 | IL-18 | Forward 5′-AGATGATGAGCTGGAATGCGATGC Reverse 5′-ATCTGGACGAACCACAAGCAACTG | 97 |
| 7 | PTGE | Forward 5′-GCCTTCTACAGCACGATCCTGATC Reverse 5′-GCCTTCTTCCTGAGCCTCACTTG | 80 |
| 8 | ALOX5 | Forward 5′-GCGGTTCACAATAGCCATCAACAC Reverse 5′-GCTGTAGGTCAGGTCCTTCATTGC | 139 |
| 9 | ALOX15B | Forward 5′-GTGAAGGAGCGGACAGTGAAGTG Reverse 5′-AACCAGGCATCCTCCAGGAAGAG | 95 |
| 10 | LOXHD1 | Forward 5′-CACAGACAAGACCTTCCGCTTCC Reverse 5′-GCAGTCCGTTCCTTCAGTTCCAG | 123 |
| 11 | IFN-γ | Forward 5′-TTCCTGATGGCGTGAAGAAGGTG Reverse 5′-TCGGAGGATCCACCAGCTTCTG | 129 |
| 12 | GSDMA | Forward 5′-AGCCTCACAGAAGCCATCTCCTAC Reverse 5′-GCTGCTGCTGCTCGCTGAAG | 196 |
| 13 | GSDME | Forward 5′-GCTGCGTGCCTGCTCTGATC Reverse 5′-GCTCAGTGCCAAGGTGCCATC | 88 |
| 14 | TRAF2 | Forward 5′-CGTGGTGATGAAAGGACCCA Reverse 5′-AATGATGTGCTCCCGGTTGT | 100 |
| 15 | TNF-R1 | Forward 5′-CCTGTCTGTCTTCCCTGTCC Reverse 5′-GGTGCATGGGGTCTTTTCTA | 120 |
| 16 | TRADD | Forward 5′-CTAGAGCCCAAAGGAAGTCGAT Reverse 5′-TGGCTGCTTCTCTGTGACAT | 100 |
| 17 | FADD | Forward 5′-GGGGTAAAGAGGCTGAACTCTTA Reverse 5′-TGAGTCCTATTGCACTGCTGTC | 163 |
| 18 | Nrf2 | Forward 5′-GATGTCACCCTGCCCTTAGA-3′ Reverse 5′-TCGTTCCATTTGTTCCTTCTG-3′ | 124 |
| 19 | GPX-1 | Forward 5′-AAGTGCTGCTGGTGGTCAACG Reverse 5′-GTTGGTGGCGTTCTCCTGGTG | 155 |
| 20 | GPX-3 | Forward 5′-GTGGCAGAGGAGTTCGGCAAC Reverse 5′-TCTTGACAGTGGCGATGTTGGC | 151 |
| 21 | PRDX6 | Forward 5′-GCATCCGCTTCCACGACTTCC Reverse 5′-GGCGTTGATGTCCTTGCTCCAG | 200 |
| 22 | MAP1LC3 | Forward 5′-GCTGCCAGTGCTGGACAAGAC Reverse 5′-TCCTCATCCTTCTCCTGCTCGTAG | 189 |
| 23 | Beclin-1 | Forward 5′-ACCGCAAGATTGTGGCTGAAGAC Reverse 5′-TGAGCATAACGCATCTGGTTCTCC | 163 |
| 24 | mTOR | Forward 5′-AACCACTGCTCGCCACAATGC Reverse 5′-CATAGGATCGCCACACGGATTAGC | 120 |
| 25 | HO-1 | Forward 5′-TCATTGGCAAGAAGCATCCAGAGC-3′ Reverse 5′-GAACTTGGTGGCGTTGGAGACTC-3′ | 176 |
| 26 | NF-κB | Forward 5′-CACATGGTGGTGACCGCCAATAG-3′ Reverse 5′-GTGCCATCGTATGTAGTGCTGTCC-3′ | 194 |
| 27 | TNF-α | Forward 5′-TGATCGTGACACGTCTCTGC-3′ Reverse 5′-CAACCAGCTATGCACCCCAG-3′ | 88 |
| 28 | IL-6 | Forward 5′-TTCACCGTGTGCGAGAACAGC-3′ Reverse 5′-CAGCCGTCCTCCTCCGTCAC-3′ | 80 |
| 29 | IL-1β | Forward 5′-AGCAGCCTCAGCGAAGAGACC-3′ Reverse 5′-GTCCACTGTGGTGTGCTCAGAATC-3′ | 90 |
| 30 | Bax | Forward 5′-ACTCTGCTGCTGCTCTCCTCTC-3′ Reverse 5′-ATCCACGCAGTGCCAGATGTAATC-3′ | 174 |
| 31 | Caspase-3 | Forward 5′-TACCGGACTGTCATCTCGTTCAGG-3′ Reverse 5′-ACTGCTTCGCTTGCTGTGATCTTC-3′ | 166 |
| 32 | Caspase-8 | Forward 5′-GGAAGCAGTGCCAGAACTCAGAAG-3′ Reverse 5′-TTGTTGTGGTCCATGCACCGATAG-3′ | 174 |
| 33 | Caspase-9 | Forward 5′-CCGAAGGAGCAAGCACGACAG-3′ Reverse 5′-CATCTAGCATGTCAGCCAGGTCAC-3′ | 121 |
| 34 | P53 | Forward 5′-GGAGATGGAACCATTGCTGGAACC-3′ Reverse 5′-GCTCCTGCCAGTTGCTGTGATC-3′ | 113 |
| 35 | Bcl2 | Forward 5′-GAGTTCGGCGGCGTGATGTG-3′ Reverse 5′-TTCAGGTACTCGGTCATCCAGGTG-3′ | 92 |
| 36 | Cytochrome C | Forward 5′-CCTAATCGCCGTGGCCTTCTTAAC-3′ Reverse 5′-GGAGGAGGTAGATGGTCGGATTGG-3′ | 163 |
| 37 | NQO1 | Forward 5′-TCGCCGAGCAGAAGAAGATTGAAG-3′ Reverse 5′-GGTGGTGAGTGACAGCATGGC-3′ | 191 |
| 38 | GSTA2 | Forward 5′-GGAGTCAATCCGGTGGCTGTTAG-3′ Reverse 5′-GGCTCTGCTCTGCACCATCTTC-3′ | 163 |
| 39 | ATG5 | Forward 5′-GGACGCATACCAACCTGCTT Reverse 5′-TGCCATTTCAGTGGCGTACC | 200 |
| 40 | Dynein | Forward 5′-CGTTGCCAGCGTTACACCTATCC Reverse 5′-GCCAGGACTGCCACCAACAC | 163 |
| 41 | F-actin | Forward 5′-ACCTGGATTGGAGAGGATGTCAGC Reverse 5′-CGGCCTTCTTCAGCTCGTTCTTG | 160 |
| 42 | α-Tubulin | Forward 5′-GCGGCACGGCAAGTACATGG Reverse 5′-CTTGGTCTTGATGGTGGCGATGG | 94 |
| 43 | TGFβ1 | Forward 5′-GCCGACACGCAGTACACCAAG Reverse 5′-GCAGGCACGGACCACCATATTG | 168 |
| 44 | β-actin | Forward 5′-CAACACAGTGCTGTCTGGTGGTAC-3′ Reverse 5′-CTCCTGCTTGCTGATCCACATCTG-3′ | 199 |
Figure 1Effect of baicalin and MG infection on chicken thymus antioxidant activities. Antioxidant activities are displayed in this figure. The experimental groups included the control group, MG-infected group, Baicalin group (450 mg/kg) and MG-treated baicalin group (450 mg/kg). *p < 0.05 vs. the control group, and #p < 0.05 vs. the MG-infection group. The results are expressed as the mean ± SD (n = 3).
Figure 2Histopathological analysis of chicken thymus. Histopathological examination of the thymus specimens of four experimental groups is shown in this figure (scale bar = 20 mm). The experimental groups were the A control group, B MG-infected group, C baicalin group (450 mg/kg), and D MG-treated baicalin group (450 mg/kg). The photomicrographs showed obvious reticular cells (red arrows), lymphocyte exudation (white arrows) and cell necrotic debris (yellow arrows).
Figure 3Ultrastructural analysis of chicken thymus. Transmission electron microscopic examination of thymus samples from the four experimental groups is shown in this figure (scale bar = 2 µm). The experimental groups were the A control group, B MG-infected group, C baicalin group (450 mg/kg) and D MG-treated baicalin group (450 mg/kg). Clear signs of apoptosis were observed, including mitochondrial swelling (black arrows), membrane deformation (blue arrows) and broken mitochondrial cristae (yellow arrows).
Figure 4Effect of baicalin and MG infection on Pro-inflammatory cytokine activities. Pro-inflammatory cytokine activities are shown in this figure. The experimental groups included the control group, MG-infected group, baicalin group (450 mg/kg) and MG-treated baicalin group (450 mg/kg). *p < 0.05 vs. the control group, and #p < 0.05 vs. the MG-infection group. The results are expressed as the mean ± SD (n = 3).
Figure 5Heat map showing the relative mRNA expression levels of genes involved in multiple signalling pathways, including apoptosis, autophagy, Nrf2, inflammation and death receptor pathways. The mRNA expression levels of genes are shown using the indicated pseudo colour scale. The experimental groups included the control group, MG-infected group, baicalin group (450 mg/kg) and MG-treated baicalin group (450 mg/kg).
Figure 6Effect of baicalin and MG infection on apoptosis-related genes. This Figure shows the A mRNA expression and B protein expression of apoptosis-related genes in the thymus tissues of the four experimental groups. The experimental groups included the control group, MG-infected group, baicalin group (450 mg/kg) and MG-treated baicalin group (450 mg/kg). *p < 0.05 vs. the control group, and #p < 0.05 vs. the MG-infection group. The results are expressed as the mean ± SD (n = 3).
Figure 7Detection of apoptosis by TUNEL assay. Apoptosis was analysed by TUNEL assay in all experimental groups, as shown in this figure. Brown-stained nuclei (apoptotic cells) were observed in chicken thymus. The experimental groups included the A control group, B MG-infected group, C baicalin group (450 mg/kg) and D MG-treated baicalin group (450 mg/kg).
Figure 8Effect of baicalin and MG infection on the Nrf2 pathway. This figure shows the effect of the four experimental treatments on the A mRNA expression and B protein expression levels of transcription factor Nrf2 and its downstream genes in chicken thymus tissues. The experimental groups included the control group, MG-infected group, baicalin group (450 mg/kg) and MG-treated baicalin group (450 mg/kg). *p < 0.05 vs. the control group, and #p < 0.05 vs. the MG-infected group. The results are expressed as the mean ± SD (n = 3).